A randomised controlled trial of an Electronic Medication Management Assistant (EMMA®) in improving patient adherence to medicines compared to usual care

INRange (USA)0 个研究点目标入组 312 人开始时间: 2011年7月19日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•Detailed inclusion criteria are that patients must use participating pharmacies and:
•1. Be at least 18 years of age
•2. Be alert and oriented to person, place, and time
•3. Primarily use English language for written and oral communication
•4. Be on a regular prescription for furosemide or be taking four or more (but less than 20) different prescription medications
•5. Have a self-reported history of inconsistent patient self-medication management
•6. Be living in the study area
•7. Achieve a score of >24 on the Mini-Mental State Exam (Folstein, Folstein and McHugh 1975)
•8. Have dexterity and visual acuity to open the individual unit dose medicine packages used in EMMA®
•9. Have the facility in their home to permit EMMA® to communicate with its server either utilising an internet connection or utilising the EMMA® device?s built-in cellular modem

•1. Have disabilities preventing safe use of the EMMA® Device (e.g. blindness, amputation, paralysis)
•2. Have an anticipated life expectancy of less than three months
•3. Are, in the opinion of either the responsible general practitioners (GP) or the pharmacist, unsuitable for the trial e.g. severe mental illness; other family circumstances
•4. Are known to be intentionally non-adherent to their medication regimen
•5. Are already receiving their medication in an MDS (monitored dosage system)

发起方

INRange (USA)